Short-term effects of lovastatin therapy on proteinuria of type 2 diabetic nephropathy: A clinical trial study

BACKGROUND: Diabetic nephropathy (DN) is characterized by albuminuria, hypertension, and a progressive decline in glomerular filtration rate. The 3-hydroxy-3-methylglutaryl coenzyme A is a well-known agent that is active in lowering total plasma and low-density lipoprotein cholesterol (LDL-C) levels...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Niger Med J
Egile Nagusiak: Sadighi, Alireza, Safa, Javid, Vatankhah, Amir-Mansour, Ghorashi, Sona, Aharilahagh, Aida, Davari-Farid, Sina, Nezami-Nargabad, Ourmaan, Naghavi-Behzad, Mohammad, Piri, Reza, Pishahang, Parinaz, Babapoor-Farrokhran, Savalan, Fakour, Sanam, Ghodratnezhad-Azar, Nastaran
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Medknow Publications & Media Pvt Ltd 2016
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036295/
https://ncbi.nlm.nih.gov/pubmed/27833243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0300-1652.190600
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak